ERBB2 and breast carcinoma: To assess the performance of mclSTExp, we analyze the HER2+ breast cancer dataset, which includes 32 tissue sections, the cSCC dataset with 12 tissue sections, and the Alex+10x dataset with 9 slices (Table 1).